Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxol/VP-16/Estramustine vs Ketoconazole/Doxorubicin/Vinblastine/Estramustine in Prostate Cancer
NCT00003084Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 1997
- Primary completion
- Nov 2002
- Modality
- Cytokines & Interferons, Small Molecules, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, etoposide in prostate cancer (PCa), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 1997; status: completed.
02
Drugs
Paclitaxel Micelles for Injectionetoposide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003084.